Emerging concepts on drug resistance in bladder cancer: Implications for future strategies

This publication has 76 references indexed in Scilit:

• ERCC1 Isoform Expression and DNA Repair in Non–Small-Cell Lung Cancer
  New England Journal of Medicine, 2013
• Update on Chemotherapy in the Treatment of Urothelial Carcinoma
  The Scientific World Journal, 2011
• The prognostic significance of human equilibrative nucleoside transporter 1 expression in patients with metastatic bladder cancer treated with gemcitabine‐cisplatin‐based combination chemotherapy
  BJU International, 2010
• Phase 2 trial of sorafenib in patients with advanced urothelial cancer
  Cancer, 2009
• Potential Mechanisms of Resistance to Microtubule Inhibitors
  Seminars in Oncology, 2008
• Autophagy in the Pathogenesis of Disease
  Cell, 2008
• FGFR3 protein expression and its relationship to mutation status and prognostic variables in bladder cancer
  The Journal of Pathology, 2007
• Gene expression of ERCC1 as a novel prognostic marker in advanced bladder cancer patients receiving cisplatin-based chemotherapy
  Annals of Oncology, 2007
• MicroRNA Signatures in Human Cancers
  Nature Reviews Cancer, 2006
• In vitro synergistic cytotoxicity of gemcitabine and pemetrexed and pharmacogenetic evaluation of response to gemcitabine in bladder cancer patients
  British Journal of Cancer, 2006